Evidence map›Paper›PMID 17537928›Full record

ArticleJournal of clinical microbiology2007

High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses.

Wai-Ming Lee, Kris Grindle, Tressa Pappas, David J Marshall, Michael J Moser, Edward L Beaty, Peter A Shult, James R Prudent, James E Gern

Registry-linked trialOpen access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00114881 (Urban Environment and Childhood Asthma), which is not on this map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00114881 completednot on this map

Urban Environment and Childhood Asthma (URECA)

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2005 to 2024Enrolled560ConditionsAsthma, Allergy
3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 224 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Comparison of risk factors for viral and nonviral asthma exacerbations.The Journal of allergy and clinical immunology · 2015
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2011
    Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Viral and non-viral episodes of wheezing in early life and the development of asthma and respiratory phenotypes among urban children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2020
    Article
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Wai-Ming LeeDepartment of Pediatrics and Medicine, University of Wisconsin, Madison, Wisconsin, USA. wlee5@wisc.edu
Kris Grindle
Tressa Pappas
David J Marshall
Michael J Moser
Edward L Beaty
Peter A Shult
James R Prudent
James E Gern
University of Wisconsin–Madison · US

Funding

RV-Mediated Mechanisms of Neutrophil Motility /InflammatU19AI070503 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2006 to 2010
$6.8M
NIAID NIH HHS U19 AI070503
6 · The paper itself

Abstract

Human respiratory viruses are a diverse group of pathogens composed of hundreds of virus strains, and this presents a major challenge for diagnostic laboratories. To efficiently detect numerous viruses in a large epidemiologic study, we developed a fast, multitarget, sensitive, and specific assay named the Respiratory MultiCode-PLx Assay (RMA). The RMA utilizes improved multiplex PCR chemistry (EraGen MultiCode-PLx technology) coupled with high-throughput microsphere flow cytometry (Luminex). Eighteen sets of virus-specific multiplex PCR primers were developed based on the conserved sequences of all available respiratory-virus sequences for eight distinct groups: human rhinovirus (HRV), respiratory syncytial virus (RSV), parainfluenza virus (PIV), influenza virus (InfV), metapneumovirus, adenovirus (Ad), coronavirus, and enterovirus. Each primer set detected 20 cDNA copies of the intended target per sample and had no reaction with 60,000 copies of human genomic DNA. The accuracy and sensitivity of the RMA for detecting respiratory viruses in human samples were tested with two sets of clinical specimens. First, 101 nasal-wash specimens that were positive for HRV, RSV, InfV, PIV, or Ad by traditional techniques were reanalyzed by RMA, and all target viruses were detected with an overall sensitivity of 94% and specificity of 99%. Second, 103 nasal-wash samples from 5-year-old children with asthma and respiratory symptoms were analyzed; RMA detected viruses in 74 specimens (71.8%) compared to only 24 (23.3%) by traditional culture and immunofluorescent-staining techniques. These results show that RMA is an accurate, sensitive, and practical test for respiratory-virus infections.

Indexed as

AdultChild, PreschoolDNA PrimersFlow CytometryFluorescent Antibody TechniqueHumansNasal Lavage FluidPolymerase Chain ReactionRespiratory Tract InfectionsSensitivity and SpecificityVirologyVirus CultivationVirusesDNA Primers

Identifiers

PMID17537928
PMCPMC1951217
OpenAlexW2160567265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.